Artivion Inc

AORT

Company Profile

  • Business description

    Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

  • Contact

    1655 Roberts Boulevard North West
    KennesawGA30144
    USA

    T: +1 770 419-3355

    E: [email protected]

    https://www.artivion.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,800

Stocks News & Analysis

stocks

Two ASX shares get takeover bids

Our take on the two bids.
stocks

Anthropic and OpenAI face commodification threats. Here’s what to watch for

Frontier AI labs face a three-pronged set of challenges.
stocks

Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment

We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,944.2031.50-0.35%
CAC 407,793.9274.13-0.94%
DAX 4025,102.49217.28-0.86%
Dow JONES (US)51,966.0336.38-0.07%
FTSE 10010,694.1470.55-0.66%
HKSE23,867.74319.09-1.32%
NASDAQ26,430.89290.851.11%
Nikkei 22564,075.42841.28-1.30%
NZX 50 Index13,631.6920.38-0.15%
S&P 5007,690.7331.290.41%
S&P/ASX 2008,816.9028.80-0.33%
SSE Composite Index3,735.374.450.12%

Market Movers